Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2008
10/23/2008US20080262039 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof For Treating Pain and Other Conditions
10/23/2008US20080262038 4-[(4-aminophenyl)(1-benzylpiperidin-4-ylidene)methyl]-N,N-diethylbenzamide; management of pain, anxiety and functional gastrointestinal disorders; delta agonist
10/23/2008US20080262037 Piperidine Derivatives for the Treatment of Chemokine Mediated Disease
10/23/2008US20080262031 4-Aminoquinoline Derivatives as Antimalarials
10/23/2008US20080262016 Isoquinoline derivatives and methods of use thereof
10/23/2008US20080262015 therapeutically active 2,4,5-trisubstituted imidazole compounds; alone or in combination; high antineoplastic activity, low systemic toxicity and low mutagenicity on normal cells; inhibitors of p38 MAP kinase; modulators of multi-drug resistance in cancer cells
10/23/2008US20080261999 Azabicycloalkane Derivatives Useful as Nicotinic Acetylcholine Receptor Agonists
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261993 surprisingly active in the control of insects and acarids; admixture with pesticides, plant growth regulators, fertilizers and soil conditioners
10/23/2008US20080261992 Pyridin-2-One Compounds and Their Use as Modulators of the Dopamine D3 Receptor
10/23/2008US20080261987 Substituted piperazines
10/23/2008US20080261977 Pyrimidine Derivatives as Cannabinoid Receptor Modulators
10/23/2008US20080261972 Cgrp Receptor Antagonists
10/23/2008US20080261971 Novel Heterocyclic Nf-Kb Inhibitors
10/23/2008US20080261965 Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases
10/23/2008US20080261964 Substituted quinolones II
10/23/2008US20080261961 Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases
10/23/2008US20080261947 Poly(ADP-ribose)polymerase inhibitor; ischemic diseases, cerebral infarction, antiretroviral, sensitizer for anticancer therapy, immunosuppressant; 5,6,7,8-tetrahydrophthalazin-1(2H)-one compounds; 2,3,4,6-tetrahydropyrido[2,3-d]pyridazin-5(1H)-one compounds
10/23/2008US20080261945 Compounds Having Activity at Nk3 Receptor and Uses Thereof in Medicine
10/23/2008US20080261944 Indole Derivatives as Antiviral Agents
10/23/2008US20080261941 Inhibitors of fatty acid amide hydrolase; N-pyridin-3-yl-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxamide; elevate brain anandamide levels; pain, urinary incontinence, cognitive disorders, anxiety, depression, sleeping, eating, movement disorders, glaucoma, psoriasis
10/23/2008US20080261940 N-(1-Arylpyrazol-4L) Sulfonamides and their Use as Parasiticides
10/23/2008US20080261917 Prodrug; novel series of compounds which inhibit the MDM2-p53 interaction and have in vitro activity exerting an anti-tumour effect; cancer
10/23/2008US20080261900 Fluoroquinolones
10/23/2008US20080261314 Fluorescent probe for zinc
10/23/2008US20080261196 Naphthalene diimide-zn(ii) complex having selectivity for pyrophosphate, preparation method thereof and detecting method of pyrophosphate using the same
10/23/2008US20080260688 Imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
10/23/2008US20080260685 Prodrugs of cc-1065 analogs
10/23/2008DE102007018151A1 Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln New vanilloid receptor ligands and their use for the preparation of medicaments
10/23/2008DE102007018149A1 Substituted compound for producing pharmaceuticals for treating or prophylaxis of pain, nerve injuries, respiratory disorder, has general formulae
10/23/2008CA2683624A1 Pharmaceutical compounds
10/23/2008CA2683622A1 2-morpholin-4-yl-pyrimidines as pi3k inhibitors
10/23/2008CA2683619A1 Pharmaceutical compounds
10/23/2008CA2683461A1 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
10/23/2008CA2683049A1 Organic compounds
10/23/2008CA2682933A1 Process for producing amide compound
10/23/2008CA2682393A1 5-membered heterocyclic derivative and use thereof for medical purposes
10/23/2008CA2682391A1 (aza)indole derivative and use thereof for medical purposes
10/23/2008CA2681783A1 Hydrazide compound and harmful arthropod-controlling agent containing the same
10/23/2008CA2681462A1 Hydrazide compound and harmful arthropod-controlling agent containing the same
10/23/2008CA2681311A1 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
10/23/2008CA2679852A1 Method for producing quinolone carboxylic acid derivative
10/22/2008EP1982982A1 Novel coumarin derivative having antitumor activity
10/22/2008EP1982978A1 Pyridone derivative and herbicide
10/22/2008EP1981882A1 Amide substituted quinolines
10/22/2008EP1981877A1 N-hydroxyacrylamide compounds
10/22/2008EP1981876A1 Triazoloanilinopyrimidine derivatives for use as antiviral agents
10/22/2008EP1981875A1 Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
10/22/2008EP1981874A1 Aminophenyl derivatives as novel inhibitors of histone deacetylase
10/22/2008EP1981873A1 Sulfonamide derivatives, preparation thereof and therapeutic use thereof
10/22/2008EP1981872A1 Succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[ (r)-2-hydroxy-2- (8-hydroxy-2-oxo-1, 2-dihydroquinolin-5-yl) eth ylaminoimethyl]} -5-methoxyphenylcarbamoyl) ethyl]piperidin-4-yl ester and its use for the treatment of pulmonary disorders
10/22/2008EP1981871A1 Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase
10/22/2008EP1981870A2 Compounds and compositions as protein kinase inhibitors
10/22/2008EP1981869A1 New citrate salt of an indole derivative and its pharmaceutical use
10/22/2008EP1981868A2 Aminophthalazine derivative compounds
10/22/2008EP1981864A1 Compounds which potentiate glutamate receptor and uses thereof in medicine
10/22/2008EP1981854A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
10/22/2008EP1981848A2 11-beta hsd1 inhibitors
10/22/2008EP1981847A1 Secondary amines as renin inhibitors
10/22/2008EP1981635A1 Use of metal complex compounds as oxidation catalysts
10/22/2008EP1981501A2 Stable pharmaceutical compositions of desloratadine and processes for preparation of polymorphic forms of desloratadine
10/22/2008EP1981500A1 Pharmaceutical use of 2-hydroxy-3- [5-(morpholin-4-ylmethyl) pyridine-2-yl]-1h- indole-5-carbonitrile as a free base or salts
10/22/2008EP1981499A1 Use of 2-imidazoles for the treatment of cns disorders
10/22/2008EP1981497A2 Use of substituted 2-imidazole of imidazoline derivatives
10/22/2008EP1756089B1 Mercaptoimidazoles as ccr2 receptor antagonists
10/22/2008EP1667647A4 Monocyclic and bicyclic lactams as factor xa inhibitors
10/22/2008EP1658269B1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
10/22/2008EP1654228B1 Tetrahydrocarbazole derivatives and their pharmaceutical use
10/22/2008EP1648879B1 Heteroaryl-tetrahydropyridyl compounds useful for treating or preventing pain
10/22/2008EP1603562A4 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
10/22/2008EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor
10/22/2008EP1318983B1 Substituted imidazoles as histamine h1 and h3 agonists or antagonists
10/22/2008CN101291927A Benzimidazoles useful as inhibitors of protein kinases
10/22/2008CN101291926A 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases
10/22/2008CN101291925A Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists
10/22/2008CN101291924A Isoindole-imide compounds and compositions comprising and methods of using the same
10/22/2008CN101291923A Pyrazolone derivatives for the treatment of tuberculosis
10/22/2008CN101291922A 烷基喹啉和烷基喹唑啉类激酶调节剂 Alkyl quinoline and alkyl quinazoline kinase modulators
10/22/2008CN101291917A Diaryl urea derivatives in the treatment of protein kinase dependent diseases
10/22/2008CN101291914A Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases
10/22/2008CN101291913A Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
10/22/2008CN101289444A Pyrimidine derivate and medicinal use thereof
10/22/2008CN101289443A Method for refining lansoprazole bulk drug
10/22/2008CN101289442A Novel benzoimidazole derivatives useful as antiproliferative agents
10/22/2008CN101289425A Enantioselective alkylation of tricyclic compounds
10/22/2008CN100427483C Anthranilic acid amide derivatives and their pharmaceutical use
10/22/2008CN100427480C Process for preparing argatroban hydrate
10/22/2008CN100427472C Aryl-heteroaromatic products, compositions containing same and use thereof
10/22/2008CN100427469C Quinoline derivatives as neutrophil elastase inhibitors and their use
10/21/2008US7439374 e.g. 4-[3-(Furo[3,2-c]pyridin-2-yl-carbonyl)-thioureido]-benzoic acid butyl ester; viricide; hepatitis C (HCV) infections, cirrhosis, end-stage liver disease, and liver cancer; side effects reducer
10/21/2008US7439367 Catalytic oxidation of sulfinyl compound; gastric ulcers; lansoprazole, omeprazole, pantoprazole, rabeprazole
10/21/2008US7439364 Process for the synthesis of derivatives of halo-[2,3-F] quinoline
10/21/2008US7439363 Substituted indazoly(indoly)maleimide derivatives as kinase inhibitors
10/21/2008US7439360 Vanilloid receptor ligands and their use in treatments
10/21/2008US7439342 Thrombopoietin mimetics
10/21/2008US7439263 e.g. 1-({[9-(hydroxymethyl)-3-oxaspiro[5.5]undec-9-yl]amino}acetyl)-2-pyrrolidinecarbonitrile; dipeptidyl-peptidase IV inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity
10/21/2008US7439258 Viral polymerase inhibitors
10/21/2008US7439257 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
10/21/2008US7439249 such as 2-(7-acetylamino-1-furano-2-ylmethyl-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-succinic acid; for treatment of autoimmune diseases, proliferative diseases, angiogenic disorders, and/or cancers; catheters, prosthetics
10/21/2008US7439242 PPARγ modulators
1 ... 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 ... 1080